Sonic Healthcare Ltd (ASX: SHL) Share Price and News

Mr Wilks became Finance Director and Chief Financial Officer of Sonic Healthcare in 1993. He was previously a partner in a private investment bank.

Prof Compton has senior executive experience in healthcare services. He is currently Adjunct Professor in Management at Macquarie University, Nonexecutive Director of The Hospitals Contribution Fund of Australia and Nonexecutive Chairman of not for profit organisations St Lukes Care and the Order of St John. He was also Chairman of the Woolcock Institute of Medical Research, Nonexecutive Director of Macquarie University Hospital and Chairman and Chancellor of St John Ambulance Australia. In recognition of his work in the healthcare sector and his service to the community, he was awarded the Centenary Medal of the Commonwealth of Australia, appointed by Her Majesty the Queen as a Knight in the Order of St John in 2004 and as Bailiff Grand Cross in 2017, and was appointed as a Member of the Order of Australia (AM) in January 2010.

Mr Mitchell has international healthcare and finance experience. He has also performed roles with a number of industry and government committees. He is a member of the Risk Management Committee.

Professor Crowe is an Emeritus Professor of Medicine at Monash University, Melbourne. She was a Nonexecutive Director of St Vincents Health Australia Ltd. She retired from Burnet Institute as Associate Director in 2018 following a 30 year research career, having played an integral role in Burnets development as a global research organisation. She retired as Principal Specialist in Infectious Diseases at The Alfred Hospital, Melbourne. She has served as a Member of the Prime Ministers Science Engineering and Innovation Council, as Head of the World Health Organization (WHO) Regional Reference Laboratory for HIV Resistance Testing and as an HIV advisor to WHO for 25 years. She was appointed a Fellow of the Australian Academy of Health and Medical Sciences in 2015, and an Officer of the Order of Australia (AO) in 2020, in recognition of her distinguished service to health and aged care administration, clinical governance, biomedical research, and to education. She is Chair of the Risk Management Committee.

Professor Bennett has over 40 years of healthcare industry experience across the private, public and not-for-profit sectors. She is an experienced nonexecutive director in forprofit and social enterprises, Patron of Research Australia, Convenor of the Champions of Change Health Coalition STEM and Health Group for gender equality, and a member of Chief Executive Women. She is also an advisor to the Digital Health Cooperative Research Centre and in 2024 completed a certificate on AI Ethics and Board Oversight. Her previous Board nonexecutive director roles include Telstra Health, HeartWare Limited, Symbion Health Limited and Chair of Sydney Childrens Hospital Network. In December 2021, she retired from and was awarded Emeritus Professor by The University of Notre Dame Australia where she was Deputy Vice Chancellor, Enterprise & Partnerships and Dean, School of Medicine, Sydney for over ten years. Her prior experience has included being Group Executive and Chief Medical Officer for MBF and then Bupa Health and Care Services; CEO and later Chair of Research Australia; Managing Director of Total Health Enterprise Ltd; Partner in Health and Life Sciences for KPMG Australia; CEO of Westmead Hospital and Community Health Services; General Manager for the Royal Hospital for Women; and Head of Planning in NSW Health. She has an active commitment to and involvement in medical professional issues, public policy and medical research. In 2008 she was appointed as Chair of the National Health and Hospitals Reform Commission producing a longterm blueprint for reform of health and aged care in Australia. She was awarded an Officer of the Order of Australia (AO) in the 2014 Australia Day Honours in recognition of her distinguished service to medicine and health care leadership. She is a member of the Risk Management Committee.

Ms Spargo has gained broad business experience as both a legal advisor, having worked in private practice and government, and as a director. She has been a director of both listed and unlisted companies for more than 20 years. She also holds nonexecutive director roles with CIMIC Group Limited, the Future Fuels Cooperative Research Centre and Geelong Football Club Limited. She was previously a Nonexecutive Director of Fletcher Building Limited, Xenith IP Group Limited, Adairs Limited and Sigma Healthcare Limited.

Ms Evans is a highly experienced nonexecutive director and business leader. Over a 35 year international career, she has gained a broad range of commercial, business management, strategy and legal experience in the financial services, health, energy and infrastructure sectors. She was a corporate advisory partner at King & Wood Mallesons for more than 20 years and also held several key management positions at the firm including Managing Partner International in Hong Kong and Managing Partner, Practice in Sydney. She is currently a member of the Australia Future Fund Board of Guardians. She is also Chair of MetLife Australia and a panel member of the Australian Governments Takeovers Panel. In 2019 she was invited by the Australian Government to be a member of the Australian delegation to the United Nations Commission on the Status of Women. She is a member of Chief Executive Women, and in 2023 was appointed as a Member of the Order of Australia (AM) in recognition of significant service to business, the law, and diversity.

Dr Giles is a registered medical practitioner with the Medical Board of Australia. After initially practicing as a medical doctor, she moved to commercial pursuits which combined science, medicine and health. She is currently Managing Director and Chief Executive Officer of OncoRes Medical, which is developing novel imaging technology to improve cancer outcomes. She is also a Venture Partner at Brandon Capital Partners, a venture capital firm dedicated to developing and supporting Australian life sciences businesses. She was previously an Investment Manager with Stone Ridge Ventures, a fund manager specialising in seed to earlystage technology investment, and a Founding Director of the Australian Governments National Reconstruction Fund Corporation. She has startup experience in medical apps, diagnostics and fitness devices and has served on the boards of private health care related technology companies. She is a member of the Curtin University Commercialisation Advisory Board

--

-

-